Li Dean Y

CIK 00018370162 companiesSALT LAKE CITY, UT

SEC Profile

Transactions

Companies

Filings

CIK

0001837016

Recent Transactions

50 trades

Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-01-02+2,381→ 1,240,909 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-10-01+1,961→ 1,238,528 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-07-01+1,949→ 1,236,567 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-06-18+22,016→ 1,234,618 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2025-06-18+44,031→ 44,031 total
Award
Merck & Co., Inc.$MRK
Stock Option (Right to Buy)
2025-04-29+64,481→ 64,481 total
Award
Merck & Co., Inc.$MRK
Restricted Stock Unit
2025-04-29+14,166→ 14,166 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-04-01+2,268→ 79,618 total
Award
Merck & Co., Inc.$MRK
Common Stock
2025-01-27$97.94/sh+32,621→ 79,592.15 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-01-02+1,647→ 77,350 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-10-01+1,925→ 75,703 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-07-01+1,592→ 73,778 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-06-03+13,097→ 72,186 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-06-03+26,193→ 26,193 total
Award
Merck & Co., Inc.$MRK
Stock Option (Right to Buy)
2024-04-30+65,625→ 65,625 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-04-01+1,267→ 59,089 total
Sale
Merck & Co., Inc.$MRK
Common Stock
2024-02-09$125.50/sh−14,702→ 46,242.37 total
Exercise/Conversion
Merck & Co., Inc.$MRK
Common Stock
2024-02-09$62.07/sh+14,702→ 60,944.37 total
Exercise/Conversion
Merck & Co., Inc.$MRK
Stock Option (Right to Buy)
2024-02-09−14,702→ 0 total
Award
Merck & Co., Inc.$MRK
Common Stock
2024-01-22$119.43/sh+25,760→ 46,242.37 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-01-09$13.65/sh−28,038→ 421,962 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-01-09$14.03/sh−962→ 421,000 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-01-02+1,203→ 1,327,618 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-10-02+1,659→ 1,326,415 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-07-03+1,609→ 637,461 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-06-16+25,224→ 25,224 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-06-16+12,612→ 636,021 total
Award
Merck & Co., Inc.$MRK
Stock Option (Right to Buy)
2023-05-02+77,455→ 77,455 total
Exercise/Conversion
Merck & Co., Inc.$MRK
Restricted Stock Unit
2023-05-01−1,062→ 0 total
Tax Payment
Merck & Co., Inc.$MRK
Common Stock
2023-05-01$115.47/sh−524→ 20,471.432 total
Exercise/Conversion
Merck & Co., Inc.$MRK
Common Stock
2023-05-01$115.47/sh+1,062→ 20,995.432 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-04-21−627,705→ 0 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-04-03+1,724→ 623,409 total
Award
Merck & Co., Inc.$MRK
Common Stock
2023-01-23$109.88/sh+3,275→ 19,933.432 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-01-03+1,573→ 621,685 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2022-10-03+1,092→ 620,112 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2022-07-01+1,409→ 619,020 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (right to buy)
2022-06-14+36,290→ 36,290 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2022-06-14+18,145→ 617,611 total
Exercise/Conversion
Merck & Co., Inc.$MRK
Restricted Stock Unit
2022-05-03−773→ 0 total
Tax Payment
Merck & Co., Inc.$MRK
Common Stock
2022-05-03$87.65/sh−381→ 16,457.945 total
Exercise/Conversion
Merck & Co., Inc.$MRK
Common Stock
2022-05-03$87.65/sh+773→ 16,838.945 total
Award
Merck & Co., Inc.$MRK
Stock Option (Right to Buy)
2022-05-03+75,728→ 75,728 total
Exercise/Conversion
Merck & Co., Inc.$MRK
Restricted Stock Unit
2022-05-01−1,061→ 1,062 total
Exercise/Conversion
Merck & Co., Inc.$MRK
Common Stock
2022-05-01$88.69/sh+1,061→ 16,588.945 total
Tax Payment
Merck & Co., Inc.$MRK
Common Stock
2022-05-01$88.69/sh−523→ 16,065.945 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2022-04-01+1,544→ 599,466 total
Award
Merck & Co., Inc.$MRK
Common Stock
2022-02-24$73.51/sh+3,023→ 15,462.118 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2022-01-03+659→ 597,922 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2021-12-07$20.44/sh−14,900→ 1,316,000 total

Companies

Recent Filings

Address

C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET

SALT LAKE CITY, UT, 84101

View on SEC.gov